Table 2 The associations of inflammatory markers with all-cause mortality and CVD mortality in postmenopausal women with osteoporosis or osteopenia

NLR

1.24 (1.14–1.34)

 < 0.001

1.17 (1.09–1.26)

 < 0.001

1.21 (1.11–1.33)

 < 0.001

1.16 (1.04–1.29)

0.007

PLR

1.06 (0.97–1.16)

0.224

1.05 (0.98–1.13)

0.131

1.00 (0.86–1.16)

0.972

0.98 (0.88–1.09)

0.669

MLR

1.36 (1.29–1.43)

 < 0.001

1.16 (1.08–1.25)

 < 0.001

1.41 (1.31–1.52)

 < 0.001

1.18 (1.05–1.33)

0.005

SII

1.18 (1.10–1.26)

 < 0.001

1.11 (1.04–1.18)

 < 0.001

1.12 (1.00–1.26)

0.043

1.09 (0.97–1.23)

0.156

SIRI

1.36 (1.29–1.44)

 < 0.001

1.21 (1.12–1.30)

 < 0.001

1.37 (1.25–1.51)

 < 0.001

1.27 (1.10–1.46)

 < 0.001

AISI

1.26 (1.18–1.34)

 < 0.001

1.13 (1.06–1.20)

 < 0.001

1.24 (1.10–1.39)

 < 0.001

1.15 (1.01–1.30)

0.032